{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T13:37:19Z","timestamp":1756993039277},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1978,1,1]],"date-time":"1978-01-01T00:00:00Z","timestamp":252460800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[1978,1]]},"DOI":"10.1007\/bf03346767","type":"journal-article","created":{"date-parts":[[2014,3,27]],"date-time":"2014-03-27T13:19:15Z","timestamp":1395926355000},"page":"25-30","source":"Crossref","is-referenced-by-count":17,"title":["Inhibition of thyrotropin and prolactin secretion by dopamine in man"],"prefix":"10.1007","volume":"1","author":[{"given":"Ferdinanda","family":"Massara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Camanni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Vergano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Belforte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. M.","family":"Molinatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,27]]},"reference":[{"key":"BF03346767_CR1","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1056\/NEJM197111182852102","volume":"285","author":"WB Malarkey","year":"1971","unstructured":"Malarkey W.B., Jacobs L.S., Daughaday W.H. Levodopa suppression of prolactin in non puerperal galactorrhea. N. Engl. J. Med. 285: 1160, 1971.","journal-title":"N. Engl. J. Med."},{"key":"BF03346767_CR2","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1172\/JCI106859","volume":"51","author":"HG Friesen","year":"1972","unstructured":"Friesen H.G., Guyda H.J., Hwang P., Tyson J.E. and Barbeau A. Functional evaluation of prolactin secretion: a guide to therapy. J.Clin. Invest. 51: 706, 1972.","journal-title":"J.Clin. Invest."},{"key":"BF03346767_CR3","first-page":"847","volume":"103","author":"E Pozo Del","year":"1973","unstructured":"Del Pozo E., Friesen H., Burmeister P. Endocrine profile of a specific prolactin inhibitor: Br-Ergocryptine (CB154). Schweiz. Med. Wochenschr. 103: 847, 1973.","journal-title":"Schweiz. Med. Wochenschr."},{"key":"BF03346767_CR4","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1210\/jcem-39-1-180","volume":"39","author":"JB Martin","year":"1974","unstructured":"Martin J.B., Lal S., Tolis G., Friesen H.G. Inhibition by apomorphine of prolactin secretion in patients with elevated serum prolactin. J. Clin. Endocrinol. Metab. 39: 180, 1974.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03346767_CR5","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1530\/acta.0.0800220","volume":"80","author":"KO Nilsson","year":"1975","unstructured":"Nilsson K.O., Wid L., Hokfelt B. The effect of apomorphine on basal and TRH stimulated release of thyrotropin and prolactin in man. Acta Endocrinol. (Kbh) 80: 220, 1975.","journal-title":"Acta Endocrinol. (Kbh)"},{"key":"BF03346767_CR6","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(76)91508-7","volume":"1","author":"F Massara","year":"1976","unstructured":"Massara F., Camanni F., Belforte L., Molinatti G.M. Dopamine-induced inhibition of PRL and GH secretion in acromegaly. Lancet 1: 485, 1976.","journal-title":"Lancet"},{"key":"BF03346767_CR7","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1210\/jcem-43-3-668","volume":"43","author":"H Leblanc","year":"1976","unstructured":"Leblanc H., Lachelin G.C.L., Abu-Fadil S., Yen S.S.C. Effects of dopamine infusion on pituitary hormone secretion in humans. J. Clin. Endocrinol. Metab. 43: 668, 1976.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03346767_CR8","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1210\/jcem-44-3-465","volume":"44","author":"F Camanni","year":"1977","unstructured":"Camanni F., Massara F., Belforte L., Rosatello A., Molinatti G.M. Effect of dopamine on plasma growth hormone and prolactin levels in normal acromegalic subjects. J. Clin. Endocrinol. Metab. 44: 465, 1977.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03346767_CR9","first-page":"471","volume":"28","author":"J Meites","year":"1972","unstructured":"Meites J., Lu K.H., Wuttke W., Welsch C.W., Nagasawa H., Quadri S.K. Recent studies on functions and control of Prolactin secretion in rats. Recent Prog. Horm. Res. 28: 471, 1972.","journal-title":"Recent Prog. Horm. Res."},{"key":"BF03346767_CR10","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1210\/endo-85-5-916","volume":"85","author":"RM Mac Leod","year":"1969","unstructured":"Mac Leod R.M. Influence of norepinephrine and catecholamine depleting agents on the synthesis and release of prolactin and growth hormone. Endocrinology 85: 916, 1969.","journal-title":"Endocrinology"},{"key":"BF03346767_CR11","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1210\/endo-86-1-120","volume":"86","author":"CA Birge","year":"1970","unstructured":"Birge C.A., Jacobs L.S., Hammer C.T., Daughaday W.H. Catecholamine inhibition of prolactin secretion by isolated rat adenohypophysis. Endocrinology 86: 120, 1970.","journal-title":"Endocrinology"},{"key":"BF03346767_CR12","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1210\/endo-95-2-462","volume":"96","author":"J Takahara","year":"1974","unstructured":"Takahara J., Arimura A., Schally A.V. Suppression of prolactin release by a purified porcine PIF preparation and catecholamines infused into a rat hypophysial portal vessel. Endocrinology 96: 462, 1974.","journal-title":"Endocrinology"},{"key":"BF03346767_CR13","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1210\/jcem-33-4-709","volume":"33","author":"RL Eddy","year":"1971","unstructured":"Eddy R.L., Jones A.L., Chakmakjian H., Silverthorne M.C. Effect of levodopa on human hypophyseal trophic hormone release. J. Clin. Endocrinol. Metab. 33: 709, 1971.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03346767_CR14","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1210\/jcem-35-1-182","volume":"35","author":"SW Spaulding","year":"1972","unstructured":"Spaulding S.W., Burrow G.N., Donabedian R., Van Woert M. L-Dopa supression of thyrotropin-releasing hormone response in man. J. Clin. Endocrinol Metab. 35: 182, 1972.","journal-title":"J. Clin. Endocrinol Metab."},{"key":"BF03346767_CR15","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1210\/jcem-39-2-391","volume":"39","author":"K Miyai","year":"1974","unstructured":"Miyai K., Onishi T., Hosokawa M., Ishibashi K., Kumahara Y. Inhibition of thyrotropin and prolactin secretion in primary hypothyroidism by 2-Br-alpha-ergocriptine. J. Clin. Endocrinol. Metab. 39: 391, 1974.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03346767_CR16","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1210\/jcem-38-3-450","volume":"38","author":"S Refetoff","year":"1974","unstructured":"Refetoff S., Fang V.S., Rapoport B., Friesen H.G. Interrelationships in the regulation of TSH and PRL secretion in man: effects of L-Dopa, TRH and thyroid hormone in various conditions. J. Clin. Endocrinol. Metab. 38: 450, 1974.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03346767_CR17","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3181\/00379727-145-37807","volume":"145","author":"T Tsukui","year":"1974","unstructured":"Tsukui T., Kanno Y., Koizumi Y., Hashizume K., Onaya T., Yamada T. Species specificity in the TSH response to the administration of L-Dopa. Proc. Soc. Exp. Biol. Med. 145: 346, 1974.","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"BF03346767_CR18","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1210\/jcem-41-5-985","volume":"41","author":"GS Besses","year":"1975","unstructured":"Besses G.S., Burrow G.N., Spaulding S.W., Donabedian R.K. Dopamine infusion acutely inhibits the TSH and prolactin response to TRH. J. Clin. Endocrinol. Metab. 41: 985, 1975.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03346767_CR19","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1210\/endo-96-1-10","volume":"96","author":"HJ Chen","year":"1975","unstructured":"Chen H.J., Meites J. Effects of biogenic amines and TRH on release of prolactin and TSH in the rat. Endocrinology 96: 10, 1975.","journal-title":"Endocrinology"},{"key":"BF03346767_CR20","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1210\/jcem-41-5-981","volume":"41","author":"R Collu","year":"1975","unstructured":"Collu R., Jequier J.C., Leboeuf G., Letarte J., Ducharme J.R. Endocrine effects of pimozide, a specific dopaminergic blocker. J. Clin. Endocrinol. Metab. 41: 981, 1975.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03346767_CR21","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000122350","volume":"17","author":"M Minozzi","year":"1975","unstructured":"Minozzi M., Faggiano M., Lombardi G., Carella C., Criscuolo T., Scapagnini V. Effect of L-Dopa on plasma TSH levels in primary hypothyroidism. Neuroendocrinology 17: 147, 1975.","journal-title":"Neuroendocrinology"},{"key":"BF03346767_CR22","first-page":"102","volume-title":"Atti XVI Congr. Soc. Italiana di Endocrinologia, Bari, 18\u201321 maggio","author":"C Ferrari","year":"1976","unstructured":"Ferrari C., Beck-Pecoz P., Paracchi A., Rondena M., Ambrosi B., Travaglini P., Spada A., Faglia G. Controllo monoaminergico delia secrezione della prolattina e dell\u2019ormone tireotropo. Atti XVI Congr. Soc. Italiana di Endocrinologia, Bari, 18\u201321 maggio 1976, Serono Symposia, p. 102."},{"key":"BF03346767_CR23","unstructured":"Massara F., Belforte L., Vergano V., Camanni F., Molinatti G.M. Inibizione della secrezione di prolattina e Tireotropina indotta dalla dopamina nell\u2019uomo. Atti XVI Congr. Soc. Italiana di Endocrinologia, Bari, 18\u201321 maggio 1976, Serono Symposia, 42, 1976."},{"key":"BF03346767_CR24","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1152\/physrev.1961.41.1.130","volume":"41","author":"J Dobbing","year":"1961","unstructured":"Dobbing J. The blood-brain barrier. Physiol. Rev. 41: 130, 1961.","journal-title":"Physiol. Rev."},{"key":"BF03346767_CR25","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1210\/endo-99-5-1407","volume":"99","author":"GM Brown","year":"1976","unstructured":"Brown G.M., Seeman P., Lee T. Dopamine neuroleptic receptors in basal hypothalamus and pituitary. Endocrinology 99: 1407, 1976.","journal-title":"Endocrinology"},{"key":"BF03346767_CR26","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1126\/science.179.4071.341","volume":"179","author":"AV Schally","year":"1973","unstructured":"Schally A.V., Arimura A., Kastin A.J. Hypothalamic regulatory hormones. Science 179: 341, 1973.","journal-title":"Science"},{"key":"BF03346767_CR27","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1677\/joe.0.0680369","volume":"68","author":"AA Gugten Van der","year":"1976","unstructured":"Van der Gugten A.A., Sahuleka P.C., Van Galen G.H., Kwa H.G. Prolactin inhibition test with L-Dopa: decrease and restoration of plasma prolactin levels in the rat by a peripheral process. Endocrinol. 68: 369, 1976.","journal-title":"Endocrinol."},{"key":"BF03346767_CR28","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1001\/archinte.1975.00330100076012","volume":"135","author":"S Reichlin","year":"1975","unstructured":"Reichlin S. Regulation of the hypophysiotropic secretions of the brain. Arch. Intern. Med. 135: 1350, 1975.","journal-title":"Arch. Intern. Med."},{"key":"BF03346767_CR29","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1159\/000121933","volume":"6","author":"RM Mac Leod","year":"1970","unstructured":"Mac Leod R.M., Fontham E.H., Lehmeyer J.E. Prolactin and growth hormone production as influenced by catecholamines and agents that affects brain catecholamines. Neuroendocrinology 6: 283, 1970.","journal-title":"Neuroendocrinology"},{"key":"BF03346767_CR30","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1210\/endo-95-5-1202","volume":"95","author":"CJ Shaar","year":"1974","unstructured":"Shaar C.J., Clemens J.A. The r\u00f4le of catecholamines in the release of anterior pituitary prolactin in vitro. Endocrinology 95: 1202, 1974.","journal-title":"Endocrinology"},{"key":"BF03346767_CR31","unstructured":"Goodman L.S., Golman A. The pharmacological basis of therapeutics. The Mac Millan Company, 559, 1965."}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03346767.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03346767\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03346767","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T20:13:50Z","timestamp":1565295230000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03346767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1978,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1978,1]]}},"alternative-id":["BF03346767"],"URL":"https:\/\/doi.org\/10.1007\/bf03346767","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[1978,1]]}}}